StockWatch
·
Pharmaceuticals
Quarterly Result14 Nov 2026, 08:32 pm

Gufic Biosciences Declares Unaudited Q2 FY27 Results

AI Summary

Gufic Biosciences Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the standalone and consolidated results during a meeting held on November 14, 2026. The filing includes the limited review report.

Key Highlights

  • Board of Directors approved unaudited financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Both standalone and consolidated results were declared.
  • A limited review report was also approved.
  • The board meeting concluded on November 14, 2026.